University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)


This is a Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-on Therapy in Symptomatic Subjects with Pulmonary Arterial Hypertension (PAH).


Please refer to identifier NCT01457781 for further information. 

Start Date
April 20, 2012
End Date
September 24, 2014
Gender Preference
Age Group
18 - 80 years
Principal Investigator
Sif Hansdottir, MD
Contact Info

Pulmonary Hypertension Program

Page Scovel, RN

phone:  319-356-1028

fax:  319-356-7087


Department or Field of Study
Heart ; High blood pressure in lungs ; PAH ; PH ; Pulmonary arterial hypertension ; Pulmonary diseases ; Pulmonary hypertension ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.